Skip to main content

Optibus believes in unicorns

Bus scheduling specialist says it's first tech firm in public transport to achieve $1bn valuation
By Adam Hill May 17, 2022 Read time: 2 mins
The Optibus team's technology is now in use in 1,000 cities worldwide (image credit: Optibus)

Optibus says it is the first tech firm dedicated to public transportation company to achieve 'unicorn' status - that is, to be privately owned but valued at more than $1 billion.

The company, an end-to-end software platform for public transportation planning, rostering and operations, has just closed $100 million in Series D funding, bringing its total funding to $260m and its valuation to $1.3bn.

Investors include Insight Partners, Bessemer Venture Partners, Verizon Ventures, Pitango First & Pitango Growth, Tencent and SOMV Momentum.

Optibus has also launched a new feature, Ridership Insights, which helps planners view and analyse real-world ridership data directly on the map, enabling them to understand how their network is performing.

The idea is that they can then leverage this to redesign services to better match passenger demand.

The company, which began in 2014, says it will use its new funding to create "a holistic software platform for all public transportation planning and operations needs, expand into new product and service offerings including real-time operations and electric vehicle management, and strengthen its global presence in existing and new markets".

Its tech is already in use in 1,000 cities worldwide.
 
"By putting powerful technology in the hands of industry professionals, Optibus helps to increase transportation equity and ridership while reducing emissions and costs," said Optibus CEO and co-founder Amos Haggiag. 

"Our investors and employees see the double promise of Optibus to generate both social good and ROI, and we are thrilled to lead the industry’s digital transformation."

Carla Stockton-Jones, UK MD at the UK's largest public transport operator, Stagecoach Group, said Optibus' "software is revolutionising our business and day-to-day operations, as well as the passenger experience".
 
Merav Rotem Naaman, general partner at investor SOMV Momentum, commented: "Optibus represents everything that is great in tech; digitising and disrupting the basic functions of society in a way that serves the common good, both in quality of service and environmental impact."

For more information on companies in this article

Related Content

  • Nearly 40% of UK councils need more funding for parking and transport programmes, says Passport
    November 29, 2018
    More than a third of UK councils say they receive inadequate funding for parking and public transportation programmes, according to software provider Passport. This figure is from Passport’s report - Solving the UK’s Traffic Challenges – which was discussed at a roundtable event in London this week. It took findings from two independent studies which Passport carried out as part of its launch in the UK. One polled 1,000 UK motorists while the other surveyed over 50 council employees working within p
  • ITS projects deliver return on investment
    December 3, 2012
    Light is being shed on where the real return on investment is today – growing, tangible, revenue-generating markets like ITS. There is a great deal of investment going on within the ITS space, and a great deal of external interest in investing in ITS,” says Scott Belcher, President and CEO of ITS America, which has been connecting investors with technology firms ripe for investment. Interested parties include the leading investment banking firm Raymond James. Its managing director, Gary Downing says: “ITS i
  • Coronavirus cripples scooter operations worldwide
    March 24, 2020
    The ongoing battle against coronavirus is causing micromobility firms to scale down and suspend operations worldwide. 
  • MaaS by any other name
    February 6, 2020
    Has the roll-out of Mobility as a Service stalled - or could it just be that multimodal travel is simply happening under a variety of different names?